Use of ASRS-v1.1 for Initial Adult ADHD Screening
The Adult ADHD Self-Report Scale (ASRS-v1.1) should be used as an initial screening instrument for adult ADHD in primary care and clinical settings, but a positive screen must always be followed by comprehensive diagnostic evaluation before treatment decisions are made.
Rationale for Using ASRS-v1.1
The ASRS-v1.1 is a practical and validated 6-question screening tool that can be completed in approximately 54 seconds 1. Research demonstrates it has excellent sensitivity (68.7-96.7%) and high negative predictive value (92.3-100%) across multiple studies 1, 2, 3, 4. This means a negative screen effectively rules out ADHD, making it highly useful for initial triage.
Key Performance Characteristics:
- Sensitivity: 68.7-96.7% depending on population and scoring method
- Specificity: 66-91.1%
- Negative Predictive Value: 92.3-100% (a negative screen strongly suggests absence of ADHD)
- Positive Predictive Value: 21.4-91.6% (varies significantly by population)
The tool performs best when scored quantitatively (0-24 points) with a cutoff of 12 points, yielding sensitivity of 96.7%, specificity of 91.1%, and kappa index of 0.88 4.
Critical Limitations and Clinical Pitfalls
1. Low Positive Predictive Value in Some Populations
The ASRS-v1.1 has significant limitations that require careful interpretation:
- In patients with major depressive disorder, positive predictive value drops to only 21.4% 5. MDD patients endorse ASRS items more frequently due to overlapping cognitive symptoms between depression and ADHD.
- The number of endorsed items correlates with anxiety levels in depressed patients 5
- A positive screen in depressed patients requires careful evaluation to distinguish whether symptoms emerge from depression versus true comorbid ADHD
2. Substance Use Disorder Populations
In treatment-seeking SUD patients, the ASRS maintains good sensitivity (84-88%) but moderate specificity (66-67%) 3. Specificity is significantly better in patients with alcohol as primary substance (76%) compared to illicit drugs (56%) 3.
3. Not a Diagnostic Tool
The ASRS-v1.1 is explicitly a screening instrument only. Even the older 2002 guidelines emphasize that determining adult ADHD requires a complete psychiatric evaluation 6. The guidelines specify structured rating scales are "useful" but must be part of comprehensive assessment.
Recommended Clinical Algorithm
Step 1: Initial Screening
- Administer ASRS-v1.1 (takes <1 minute)
- Use quantitative scoring (0-24 points) with cutoff ≥12 points for optimal performance
Step 2: Interpret Results Based on Context
If Screen is NEGATIVE:
- ADHD is highly unlikely (NPV 92.3-100%)
- No further ADHD evaluation needed unless clinical suspicion remains very high
If Screen is POSITIVE:
- Proceed to comprehensive evaluation (do not diagnose or treat based on screening alone)
- Consider patient's psychiatric comorbidities that may cause false positives:
- Major depressive disorder (very high false positive rate)
- Anxiety disorders
- Substance use disorders (especially illicit drugs)
- Bipolar disorder
Step 3: Comprehensive Diagnostic Evaluation for Positive Screens
The 2002 guidelines specify the following components are required 6:
- Complete psychiatric evaluation with focus on core ADHD symptoms starting in childhood
- Collateral information from spouse, significant other, parent, or friend (adults with ADHD have poor insight and underestimate symptom severity)
- Detailed substance abuse history and consider urine drug screen given high comorbidity rates
- Medical history, physical examination, and screening labs to rule out medical conditions mimicking ADHD
- Differential diagnosis must exclude:
- Bipolar disorder
- Depression
- Personality disorders (Axis II)
- Learning disabilities
- Narcolepsy
- Borderline intellectual functioning
Timing of Administration
The ASRS-v1.1 can be administered at intake or 1-2 weeks after intake with similar performance characteristics 3. In SUD populations, sensitivity and specificity were comparable whether measured at admission (sensitivity 0.84, specificity 0.66) or 2 weeks later (sensitivity 0.88, specificity 0.67).
Bottom Line
Use the ASRS-v1.1 as your initial screening tool because of its speed, high sensitivity, and excellent ability to rule out ADHD when negative. However, never diagnose or treat based on a positive screen alone—the moderate positive predictive value (especially in depressed patients) means many positive screens will be false positives. Always follow positive screens with the comprehensive diagnostic evaluation outlined in clinical guidelines, including collateral information from others, childhood symptom history, substance abuse assessment, and careful evaluation of differential diagnoses 6, 1, 2, 5, 3.